Yale serous‑fluid session
Yale pathology is promoting an upcoming session on serous fluid cytopathology by Minhua Wang, MD, PhD that will cover clinical approaches and diagnostic challenges for body‑fluid specimens. The talk is presented as relevant for cytology practice in teaching hospitals. (x.com)
Yale Pathology is promoting an upcoming teaching session on serous fluid cytopathology, a lab specialty that reads cells floating in body-cavity fluid. (x.com) Serous fluid means the liquid that can collect around the lungs, heart, or abdominal organs in the pleural, pericardial, and peritoneal spaces. Cytopathology is the microscope-based review of those cells to help sort cancer from infection, inflammation, or other causes of an effusion. (springer.com) The speaker, Minhua Wang, is a Yale School of Medicine pathologist whose clinical work includes cytopathology and gynecological pathology. Yale’s faculty profile says she studies fluid, smear, and aspiration specimens to make diagnoses. (medicine.yale.edu) The field has been pushing toward more standardized language for these cases. The International System for Reporting Serous Fluid Cytopathology, published in 2020 by the International Academy of Cytology and the American Society of Cytopathology, set out five categories from non-diagnostic to malignant. (acsjournals.onlinelibrary.wiley.com) That framework was meant to fix a practical problem: different labs and clinicians were using inconsistent terms for the same kinds of body-fluid findings. Reviews of the system say the goal was clearer communication and more reproducible diagnoses in pleural, peritoneal, and pericardial specimens. (acsjournals.onlinelibrary.wiley.com) (captodayonline.com) Wang has published in this area with Yale colleagues. A 2023 study from Yale applied the reporting system to pericardial fluid and examined diagnostic performance and malignancy risk across categories. (pubmed.ncbi.nlm.nih.gov) She also co-authored a 2023 review that described diagnostic pitfalls and a practical approach to serous-fluid specimens. That review said indeterminate cases can stem from low cellularity, degenerative change, or overlap between reactive mesothelial cells and malignant cells. (publinestorage.blob.core.windows.net) The session appears to be part of a broader online education lineup. The Chinese American Pathologists Association lists an April 12 lecture titled “Serous Fluid Cytopathology - Clinical Approach and Diagnostic Challenges” by Minhua Wang of Yale University. (capa-ht.org) For teaching hospitals, the topic sits at the junction of lab interpretation and bedside decisions: a few milliliters of fluid can shape whether a patient gets more imaging, repeat sampling, or cancer staging workup. Yale’s post points to that day-to-day diagnostic work, not a new test, as the focus of the session. (x.com) (springer.com)